Societe Generale’s Usana Health Sciences USNA Stock Holding History

Societe Generale’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.62M	Buy	+29,034	New	+$1.75M	0.01%	981

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Societe Generale's USNA Position: Q2 2016 in Review

Societe Generale opened a new position in Usana Health Sciences (USNA) in Q2 2016: 29,034 shares worth $1.62M. The stake represents 0.01% of the portfolio and ranks #981 among its holdings.

142 funds tracked by Wall St. Rank hold USNA as of Q2 2016.

Societe Generale held 29,034 shares of Usana Health Sciences worth $1.62M as of Q2 2016.
Usana Health Sciences was a new Societe Generale position in Q2 2016.
Usana Health Sciences made up 0.01% of Societe Generale's portfolio in Q2 2016, its #981 holding.
142 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.